title: Access to diabetes drugs in New Zealand is inadequate.
authors.affiliation: Endocrine, Diabetes and Research Centre, Wellington Regional Hospital, Wellington, New Zealand. jeremy.krebs@ccdhb.org.nz.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Krebs
authors.forename: Kirsten J
authors.initials: KJ
authors.lastname: Coppell
authors.forename: Pip
authors.initials: P
authors.lastname: Cresswell
authors.forename: Michelle
authors.initials: M
authors.lastname: Downie
authors.forename: Paul
authors.initials: P
authors.lastname: Drury
authors.forename: Ann
authors.initials: A
authors.lastname: Gregory
authors.forename: Timothy
authors.initials: T
authors.lastname: Kenealy
authors.forename: Catherine
authors.initials: C
authors.lastname: McNamara
authors.forename: Steven Cm
authors.initials: SC
authors.lastname: Miller
authors.forename: Kate
authors.initials: K
authors.lastname: Smallman
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D016527:Drug Costs; D005380:Financing, Government; D052216:Glucagon-Like Peptide 1 / Q000819:agonists; D006442:Glycated Hemoglobin / Q000378:metabolism; D006297:Health Services Accessibility / Q000191:economics; D061889:Healthcare Financing; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D009520:New Zealand; D017410:Practice Guidelines as Topic; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors; C517652:hemoglobin A1c protein, human